| Page 93 | Kisaco Research
 

Linda Block

Investor
Impactology Partners

Linda Block

Investor
Impactology Partners

Linda Block

Investor
Impactology Partners
 

Jeffrey Emmons

VP Venture and Growth
Emil Capital Partners

Jeffrey Emmons

VP Venture and Growth
Emil Capital Partners

Jeffrey Emmons

VP Venture and Growth
Emil Capital Partners
 

Lukasz Bzdzion

Founder & CEO
Bioceltix

Lukasz Bzdzion

Founder & CEO
Bioceltix

Lukasz Bzdzion

Founder & CEO
Bioceltix
 

Ashley Pochick

VP Supplier Relations
Inventory Ally

Ashley Pochick

VP Supplier Relations
Inventory Ally

Ashley Pochick

VP Supplier Relations
Inventory Ally
 

Giovani Abruzzini

CEO
Virbac

Giovani Abruzzini

CEO
Virbac

Giovani Abruzzini

CEO
Virbac
 

Martin Seneviratne

Co-Founder
Phare Health

Martin Seneviratne

Co-Founder
Phare Health

Martin Seneviratne

Co-Founder
Phare Health
 

Bradford Kuntscher

Product Specialist
Iodine Software

Bradford Kuntscher

Product Specialist
Iodine Software

Bradford Kuntscher

Product Specialist
Iodine Software

Price Transparency Rule Changes will have a profound effect on the accuracy and value of Hospital and Health Plan Price Transparency data.  We will review those changes and the impact to health plans in terms of business intelligence, competitive positioning, and payment integrity use cases.

Payment Integrity

Author:

John-Michael Loke

SVP, Health Plan Strategy & Partnerships
AMS

John-Michael Loke

SVP, Health Plan Strategy & Partnerships
AMS
 

Natalie Clayton

Head of Market Intelligence
Kisaco Research

Natalie Clayton

Head of Market Intelligence
Kisaco Research

Natalie Clayton

Head of Market Intelligence
Kisaco Research